KLRC1 and acute myeloid leukemia: However, when analyzing the individual AML cases, the percentage of hypermature CD159a–positive NK cells did not significantly decrease compared to the mature population (P = 0.1990, Supplementary Figure 4C), thus suggesting an actual increase in the number of hypermature NKG2A-expressing cells.